Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00772265 · ClinicalTrials.gov registry record · Phase 1

Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects

A Phase 1 study, sponsored by Wockhardt.

Completed
Registry status
Phase 1
Development phase
56
Enrollment target

NCT00772265: Completed Phase 1 study, sponsored by Wockhardt.

NCT00772265 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 56 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00772265, a Phase 1 study, has completed, sponsored by Wockhardt.

COMPLETED
Registry status
Phase 1
Development phase
56 participants
Enrollment target

Study Summary

The aim of this trial is to demonstrate bioequivalence of Wosulin N to Novolin® N with regard to its total and to its maximum serum insulin concentrations.

Interventions

  • BIOLOGICAL Wosulin N
  • BIOLOGICAL Novolin N

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2010-09
Est. Completion 2011-04
Phase Phase 1
Wockhardt

27 total trials

What the finished NCT00772265 record still lists

NCT00772265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.

The record links to 0 conditions, and to 2 interventions - of which Wosulin N is the first listed.

NCT00772265 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00772265 about?

NCT00772265 is a clinical study titled "Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects". The aim of this trial is to demonstrate bioequivalence of Wosulin N to Novolin® N with regard to its total and to its maximum serum insulin concentrations.

What is the current status of trial NCT00772265?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2010-09. Estimated completion is 2011-04.

What interventions are being tested in trial NCT00772265?

The interventions under investigation include: Wosulin N (BIOLOGICAL), Novolin N (BIOLOGICAL).

Who is sponsoring clinical trial NCT00772265?

This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00772265's enrollment target sits among peer trials

56 902nd of 2000 higher than 1,083 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00772265, the US trial registry maintained by the National Library of Medicine. NCT00772265 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.